Biodesix

Biodesix

A molecular diagnostics company at the forefront of innovation in oncology.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*
N/A

$55.0m

Private Placement VC
Total Funding000k
Innovatus
Innovatus(exited)
CRG LP
CRG LP(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth86 %20 %(30 %)28 %45 %15 %29 %
EBITDA0000000000000000000000000000
% EBITDA margin(48 %)(72 %)(132 %)(73 %)(40 %)--
Profit0000000000000000000000000000
% profit margin(69 %)(79 %)(171 %)(106 %)(60 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue24 %23 %34 %20 %13 %--

Source: Company filings or news article, Equity research estimates

More about Biodesix
Made with AI
Edit

Biodesix is a data-driven diagnostic solutions company that leverages state-of-the-art technologies and proprietary artificial intelligence (AI) platforms to discover, develop, and commercialize solutions for clinical unmet needs, primarily focusing on lung disease. The company aims to improve patient outcomes and reduce healthcare costs by providing accurate diagnostic tools that minimize ineffective treatments. Biodesix serves healthcare providers, hospitals, and research institutions, operating within the healthcare diagnostics market. The business model revolves around the development and sale of diagnostic tests, as well as offering related services. Revenue is generated through the sale of these diagnostic tests and partnerships with healthcare providers and research organizations.

Keywords: diagnostic solutions, artificial intelligence, lung disease, patient outcomes, healthcare costs, clinical unmet needs, healthcare providers, hospitals, research institutions, diagnostic tests.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Biodesix

Edit
Integrated Diagnostics
ACQUISITION by Biodesix Jul 2018
Oncimmune
ACQUISITION by Freenome May 2023